• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nrf2 通过调节 CYP2C9 活性改善房颤抗栓治疗期间的心房纤维化。

Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity.

机构信息

Medical Laboratory, Shidong Hospital, Yangpu District, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, China.

School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai, China ; and.

出版信息

J Cardiovasc Pharmacol. 2024 Oct 1;84(4):440-450. doi: 10.1097/FJC.0000000000001618.

DOI:10.1097/FJC.0000000000001618
PMID:39150397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11446533/
Abstract

Anticoagulant therapy can significantly reduce the incidence of stroke and peripheral embolism events in patients with atrial fibrillation (AF). Although warfarin is widely used as an anticoagulant drug, a wrong dose can lead to increased risks of bleeding or blood clots. The aim of this study was to assess whether nuclear factor-erythroid-2-related factor 2 (Nrf2) can improve the efficacy of warfarin through the regulation of cytochrome P450 family 2 subfamily C member 9 (CYP2C9) using a rat model of AF. Results showed that AF significantly reduced Nrf2 in myocardial tissue of sham-operated rats. Furthermore, Nrf2 overexpression effectively reduced AF-induced atrial fibrosis by reducing collagen in the left atrium, inhibiting the expression of the fibrosis-related genes collagen I and transforming growth factor-β1 in rats with AF. Nrf2 overexpression can activate CYP2C9, decrease the serum concentration of warfarin, and decrease prothrombin time and international normalized ratio in AF rats. In this article, Nrf2 overexpression protects against fibrosis, increased survival in AF rats, and activated CYP2C9 expression, thus broadening the therapeutic range of warfarin in AF rats.

摘要

抗凝治疗可显著降低房颤(AF)患者中风和外周栓塞事件的发生率。虽然华法林被广泛用作抗凝药物,但剂量错误会导致出血或血栓形成的风险增加。本研究旨在评估核因子-红细胞 2 相关因子 2(Nrf2)是否可以通过调节细胞色素 P450 家族 2 亚家族 C 成员 9(CYP2C9),改善 AF 大鼠模型中华法林的疗效。结果表明,AF 显著降低了假手术大鼠心肌组织中的 Nrf2。此外,Nrf2 的过表达通过减少左心房中的胶原,抑制 AF 大鼠中纤维化相关基因胶原 I 和转化生长因子-β1 的表达,有效减少了 AF 引起的心房纤维化。Nrf2 的过表达可以激活 CYP2C9,降低 AF 大鼠中华法林的血清浓度,并降低凝血酶原时间和国际标准化比值。在本文中,Nrf2 的过表达可防止纤维化,增加 AF 大鼠的存活率,并激活 CYP2C9 的表达,从而拓宽了 AF 大鼠中华法林的治疗范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/89322d03a7ed/jcvp-84-440-s001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/5e0710d20452/jcvp-84-440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/d5ed9a7b6aa4/jcvp-84-440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/d3003f90fe6b/jcvp-84-440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/35c710481f07/jcvp-84-440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/02d7d4365f86/jcvp-84-440-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/0cb2231e9c0b/jcvp-84-440-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/89322d03a7ed/jcvp-84-440-s001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/5e0710d20452/jcvp-84-440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/d5ed9a7b6aa4/jcvp-84-440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/d3003f90fe6b/jcvp-84-440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/35c710481f07/jcvp-84-440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/02d7d4365f86/jcvp-84-440-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/0cb2231e9c0b/jcvp-84-440-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9547/11446533/89322d03a7ed/jcvp-84-440-s001.jpg

相似文献

1
Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity.Nrf2 通过调节 CYP2C9 活性改善房颤抗栓治疗期间的心房纤维化。
J Cardiovasc Pharmacol. 2024 Oct 1;84(4):440-450. doi: 10.1097/FJC.0000000000001618.
2
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.在心房颤动患者中,Xa因子抑制剂与维生素K拮抗剂预防脑栓塞或全身性栓塞的比较
Cochrane Database Syst Rev. 2013 Aug 8(8):CD008980. doi: 10.1002/14651858.CD008980.pub2.
3
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.直接口服抗凝剂与华法林在预防慢性肾脏病房颤患者中风和全身性栓塞事件方面的比较
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD011373. doi: 10.1002/14651858.CD011373.pub2.
4
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.在房颤患者中,Xa因子抑制剂与维生素K拮抗剂预防脑栓塞或全身性栓塞的比较。
Cochrane Database Syst Rev. 2018 Mar 6;3(3):CD008980. doi: 10.1002/14651858.CD008980.pub3.
5
Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway.维立西呱通过TGF-β1/Smad2/3信号通路减轻心肌纤维化,从而降低房颤复发率。
PLoS One. 2025 Jul 18;20(7):e0328272. doi: 10.1371/journal.pone.0328272. eCollection 2025.
6
New oral anticoagulants for atrial fibrillation: a review of clinical trials.新型口服抗凝药物在心房颤动中的应用:临床试验研究综述。
Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13.
7
Berberine improves atrial remodeling by regulating the AMPK/PPARα signaling pathway in a rabbit model of atrial fibrillation.黄连素通过调节兔心房颤动模型中的AMPK/PPARα信号通路改善心房重构。
J Appl Biomed. 2025 Jun;23(2):63-79. doi: 10.32725/jab.2025.007. Epub 2025 May 27.
8
Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.细胞色素P450 2C9基因多态性与儿童患者华法林维持剂量:一项系统评价和荟萃分析。
Cardiovasc Ther. 2017 Feb;35(1):26-32. doi: 10.1111/1755-5922.12230.
9
Inhibition of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders.抑制α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体可改善焦虑障碍大鼠的心房炎症和心房颤动易感性。
J Cardiovasc Pharmacol. 2024 Aug 1;84(2):227-238. doi: 10.1097/FJC.0000000000001593.
10
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.口服抗凝剂用于静脉血栓栓塞性疾病的一级预防、治疗和二级预防,以及用于心房颤动的卒中预防:系统评价、网状荟萃分析和成本效益分析。
Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090.

引用本文的文献

1
Potential novel diagnostic biomarkers of atrial fibrillation: four ferroptosis-related genes linking immune infiltration.心房颤动潜在的新型诊断生物标志物:四个与铁死亡相关且与免疫浸润相关的基因
Eur J Med Res. 2025 Aug 26;30(1):805. doi: 10.1186/s40001-025-03092-3.
2
The combination of hyaluronic acids and collagen boosts human Achilles tendon-derived cell escape from inflammation and matrix remodeling in vitro.透明质酸和胶原蛋白的组合可促进源自人跟腱的细胞在体外摆脱炎症并进行基质重塑。
Inflamm Res. 2025 Jan 7;74(1):4. doi: 10.1007/s00011-024-01975-5.
3
Plasma metabolomic characteristics of atrial fibrillation patients with spontaneous echo contrast.
自发性回声对比的心房颤动患者的血浆代谢组学特征。
BMC Cardiovasc Disord. 2024 Nov 16;24(1):654. doi: 10.1186/s12872-024-04306-y.